Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024
Clinical trial NCT06683937 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06683937
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.